The views expressed in this presentation are those of the CPSC staff,
have not been reviewed or approved by, and may not necessarily
reflect the views of, the Commission.
1
Poison Prevention
Packaging
Act
2
 Issue regulations requiring special
packaging for household substances
 15 U.S.C. § 1472(a)
 Other statutes provide for
enforcement of PPPA regulations
 Consumer Product Safety Act
 Federal Hazardous Substances Act
3
 Child-resistant
◦ significantly difficult for children <5 to
open or obtain a toxic or harmful amount
of the substance within a reasonable time
 Adult (Senior) Friendly
◦ not difficult for normal adults to use
properly
15 U.S.C. § 1471(4)
4
 Customarily produced or distributed
for sale for consumption or use, or
customarily stored, by individuals in or
about the household, and which is
◦ a hazardous substance as defined by the
Federal Hazardous Substances Act (FHSA);
◦ a food, drug, or cosmetic as defined by the
Food, Drug and Cosmetic Act (FD&CA); or
5
◦ substance intended for use as
fuel when stored in a portable
container and used in the
heating, cooking, or refrigeration
system of a house.
15 U.S.C. § 1471(2)
6
 The child-resistance requirements
apply to the immediate container or
wrapping.
 Not a shipping container
 Not outer wrapping
15 U.S.C. § 1471(3)
7
 The Act contains provisions to
ensure that elderly or handicapped
individuals unable to use special
packaging can obtain regular
packaging
 Section 4 allows for limited use of
non-complying packaging to
achieve this
15 U.S.C. § 1473
8
 Manufacturer (or packer) may supply non-
prescription substance in a single non-
complying size package
 Label: For households without young children
 Physician can specify non-CR packaging in
prescription
 Patient can request non-CR packaging when
filling prescription
15 U.S.C. § 1473
9
Commission findings:
 special packaging is required to protect
children from serious personal injury or
serious illness resulting from handling,
using, or ingesting household substances.
 special packaging is technically feasible,
practicable, and appropriate for those
substances.
15 U.S.C. § 1472(a)
10
The Commission must consider:
 Reasonableness of the standard
 Available scientific, medical,
and engineering data
 Manufacturing practices of
affected industry
 Nature and use of the substance
15 U.S.C. § 1472(b)
11
 Cannot prescribe specific
packaging designs, product
content, package quantity, or
(with one exception) labeling
15 U.S.C. § 1472(d)
12
 Can prohibit packaging that is
“unnecessarily attractive” to
children
15 U.S.C. § 1472(d)
13
 Notice and comment rulemaking
(15 U.S.C. § 1474(a))
 No cost benefit analysis is required
(15 U.S.C. § 1472(e))
14
 Not sooner than 180 days unless
Commission finds it is in the
public interest
 Not later than 1 year
 Applies to products packaged on
or after effective date
15 U.S.C. § 1471n
15
 Not customarily used in/around the
household
 Specifically exempted at 16 CFR § 1700.14(a)
 Bulk packages of drugs sold to pharmacies
that will be repackaged by pharmacist before
being dispensed
 Bulk chemicals sold to industry
 Containers of 5 gallons or more (unless
otherwise indicated in a regulation)
16
Public Law 114-116
Jan. 28, 2016
17
 Any nicotine provided in a liquid nicotine
container sold, offered for sale, manufactured
for sale, distributed in commerce, or
imported into the United States shall be
packaged in accordance with the standards
provided in 16 CFR § 1700.15.
 This requirement shall be treated as a
standard for special packaging of a
household substance under the PPPA.
18
 Act provided that requirement would
take effect 180 days after enactment
 July 26, 2016
19
 Food and Drug Administration has issued
final regulations concerning electronic
cigarettes and related products and
components, 81 FR 28974 (May 10, 2016).
 Currently, no FDA regulations on packaging
of liquid nicotine.
20
 Child Nicotine Poisoning Prevention Act has
savings clause that would allow FDA to issue
regulations or take other action regarding
liquid nicotine (including child-resistant
packaging) in the future.
 Act calls for consultation and coordination
between CPSC and FDA.
21

PPPA Statutes - 2016

  • 1.
    The views expressedin this presentation are those of the CPSC staff, have not been reviewed or approved by, and may not necessarily reflect the views of, the Commission. 1
  • 2.
  • 3.
     Issue regulationsrequiring special packaging for household substances  15 U.S.C. § 1472(a)  Other statutes provide for enforcement of PPPA regulations  Consumer Product Safety Act  Federal Hazardous Substances Act 3
  • 4.
     Child-resistant ◦ significantlydifficult for children <5 to open or obtain a toxic or harmful amount of the substance within a reasonable time  Adult (Senior) Friendly ◦ not difficult for normal adults to use properly 15 U.S.C. § 1471(4) 4
  • 5.
     Customarily producedor distributed for sale for consumption or use, or customarily stored, by individuals in or about the household, and which is ◦ a hazardous substance as defined by the Federal Hazardous Substances Act (FHSA); ◦ a food, drug, or cosmetic as defined by the Food, Drug and Cosmetic Act (FD&CA); or 5
  • 6.
    ◦ substance intendedfor use as fuel when stored in a portable container and used in the heating, cooking, or refrigeration system of a house. 15 U.S.C. § 1471(2) 6
  • 7.
     The child-resistancerequirements apply to the immediate container or wrapping.  Not a shipping container  Not outer wrapping 15 U.S.C. § 1471(3) 7
  • 8.
     The Actcontains provisions to ensure that elderly or handicapped individuals unable to use special packaging can obtain regular packaging  Section 4 allows for limited use of non-complying packaging to achieve this 15 U.S.C. § 1473 8
  • 9.
     Manufacturer (orpacker) may supply non- prescription substance in a single non- complying size package  Label: For households without young children  Physician can specify non-CR packaging in prescription  Patient can request non-CR packaging when filling prescription 15 U.S.C. § 1473 9
  • 10.
    Commission findings:  specialpackaging is required to protect children from serious personal injury or serious illness resulting from handling, using, or ingesting household substances.  special packaging is technically feasible, practicable, and appropriate for those substances. 15 U.S.C. § 1472(a) 10
  • 11.
    The Commission mustconsider:  Reasonableness of the standard  Available scientific, medical, and engineering data  Manufacturing practices of affected industry  Nature and use of the substance 15 U.S.C. § 1472(b) 11
  • 12.
     Cannot prescribespecific packaging designs, product content, package quantity, or (with one exception) labeling 15 U.S.C. § 1472(d) 12
  • 13.
     Can prohibitpackaging that is “unnecessarily attractive” to children 15 U.S.C. § 1472(d) 13
  • 14.
     Notice andcomment rulemaking (15 U.S.C. § 1474(a))  No cost benefit analysis is required (15 U.S.C. § 1472(e)) 14
  • 15.
     Not soonerthan 180 days unless Commission finds it is in the public interest  Not later than 1 year  Applies to products packaged on or after effective date 15 U.S.C. § 1471n 15
  • 16.
     Not customarilyused in/around the household  Specifically exempted at 16 CFR § 1700.14(a)  Bulk packages of drugs sold to pharmacies that will be repackaged by pharmacist before being dispensed  Bulk chemicals sold to industry  Containers of 5 gallons or more (unless otherwise indicated in a regulation) 16
  • 17.
  • 18.
     Any nicotineprovided in a liquid nicotine container sold, offered for sale, manufactured for sale, distributed in commerce, or imported into the United States shall be packaged in accordance with the standards provided in 16 CFR § 1700.15.  This requirement shall be treated as a standard for special packaging of a household substance under the PPPA. 18
  • 19.
     Act providedthat requirement would take effect 180 days after enactment  July 26, 2016 19
  • 20.
     Food andDrug Administration has issued final regulations concerning electronic cigarettes and related products and components, 81 FR 28974 (May 10, 2016).  Currently, no FDA regulations on packaging of liquid nicotine. 20
  • 21.
     Child NicotinePoisoning Prevention Act has savings clause that would allow FDA to issue regulations or take other action regarding liquid nicotine (including child-resistant packaging) in the future.  Act calls for consultation and coordination between CPSC and FDA. 21